FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Free Newsletter

About | View Sample | Privacy
Related Topics >> FDA | Bayer | Wyeth | Warfarin | Superbugs

ALSO NOTED: Genetic test for warfarin sensitivity OK'd; Bayer boosts OTC production

Tools

> The FDA also cleared a new genetic test to determine over-sensitivity to the blood thinner warfarin, a month after updating drug labeling to alert doctors that patients carrying certain genes respond differently. Release

> Bayer is ramping up its production of OTC drugs at its Bitterfield, Germany, manufacturing plant, aiming to boost output to 6 million pills this year, up from 4.1 million in 2006. Report

And Finally... We're used to news that antibiotics can spawn resistant superbugs. But a vaccine? Apparently, Wyeth's super-successful Prevnar shot has successfully prevented pneumonia, meningitis, and other infections, but it's also cleared the way for a new, resistant strain of strep. Report


SHARE
WITH:
Email Twitter Facebook LinkedIn StumbleUpon
Get Your FREE FiercePharma Email Newsletter:

More stories about Wyeth   Warfarin   Superbugs   FDA   Bayer